Article Text

Dissolution of tungsten coils leads to device failure after transcatheter embolisation of pathologic vessels
  1. MATTHIAS PEUSTER,
  2. VOLKER KAESE*,
  3. GEROLD WUENSCH,
  4. PETRA WUEBBOLT,
  5. MATTHIAS NIEMEYER*,
  6. REGINA BOEKENKAMP,
  7. CHRISTOPH FINK,
  8. HEINZ HAFERKAMP*,
  9. GERD HAUSDORF
  1. Department of Pedatric Cardiology and Pediatric Intensive Care
  2. Hannover Medical School
  3. *Institute of Materials Science
  4. University of Hannover
  5. †Institute of Inorganic Chemistry
  6. University of Hannover
  7. Germany
  1. Dr med Matthias Peuster, Department of Pediatric Cardiology and Pediatric Intensive Care, Hannover Medical School, 30625 Hannover, Germany; Peuster.Matthias{at}MH-Hannover.de

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Coil embolisation has been the standard transcatheter technique for occlusion of pathologic vessels, aneurysms, and fistulae for more than three decades. Tungsten is an attractive material for use as an endovascular coil, because of its high radiopacity and thrombogenicity.1 Recently, decreasing radiopacity has been reported in patients after implantation of tungsten coils (MDS, Balt Extrusion, Montmorency, France) into cerebral aneurysms > 30 months after implantation.2 Analysis of the coils in an experimental study demonstrated “a clear degree of iron” around the MDS coil occluded arterial aneurysms. The authors concluded: (1) that the coils are not purely tungsten; (2) that there was corrosion of the coils; and (3) that it may be dangerous to use this type of coil in patients.3 To assess whether similar findings could be observed in our patients all transcatheter tungsten coil …

View Full Text